The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

被引:495
作者
Teutsch, Steven M. [2 ]
Bradley, Linda A. [1 ]
Palomaki, Glenn E. [3 ]
Haddow, James E. [3 ]
Piper, Margaret [4 ]
Calonge, Ned [5 ]
Dotson, W. David [1 ,6 ]
Douglas, Michael P. [1 ,6 ]
Berg, Alfred O. [7 ]
机构
[1] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, CDC, Atlanta, GA 30341 USA
[2] Merck & Co Inc, West Point, PA USA
[3] Brown Univ, Warren Alpert Med Sch, Dept Pathol & Lab Med Res, Providence, RI 02912 USA
[4] Blue Cross Blue Shield Assoc Technol Evaluat Ctr, Chicago, IL USA
[5] Colorado Dept Publ Hlth & Environm, Denver, CO USA
[6] McKing Consulting Corp, Atlanta, GA USA
[7] Univ Washington, Dept Family Med, Seattle, WA 98195 USA
关键词
Evidence-based medicine; review; systematic; SERVICES-TASK-FORCE; SYSTEMATIC REVIEWS; ANALYTIC VALIDITY; RAPID-ACCE; RECOMMENDATIONS; CHALLENGES; STRENGTH; ADULTS; TESTS; RISK;
D O I
10.1097/GIM.0b013e318184137c
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative, established by the National Office of Public Health Genomics at the Centers for Disease Control and Prevention, supports the development and implementation of a rigorous, evidence-based process for evaluating genetic tests and other genomic applications for clinical and public health practice in the United States. An independent, non-federal EGAPP Working. Group (EWG), a multidisciplinary expert panel selects topics, oversees the systematic review of evidence, and makes recommendations based on that evidence. This article describes the EGAPP processes and details the specific methods and approaches used by the EWG.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 56 条
[1]  
*ACCE, POP BAS PREN SCREEN
[2]  
*ADV COMM HER DIS, 2006, EV BAS EV DEC PROC A
[3]  
*AHRQ, SYST RAT STRENGTH SC
[4]  
*AM COLL MED GEN, C8 TEST VAL STAND GU
[5]  
*AM COLL OBST GYN, ACOGS SCREEN GUID CH
[6]  
[Anonymous], GENETIC TESTING REFE
[7]  
[Anonymous], GUID IND CL IN PRESS
[8]  
[Anonymous], PROMOTING SAFE EFFEC
[9]  
[Anonymous], LEV EV GRAD REC
[10]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490